Literature DB >> 23463871

Pathophysiological insights into ALS with C9ORF72 expansions.

Kelly L Williams1, Jennifer A Fifita, Steve Vucic, Jennifer C Durnall, Matthew C Kiernan, Ian P Blair, Garth A Nicholson.   

Abstract

OBJECTIVE: Expansions of a hexanucleotide repeat in C9ORF72 are a common cause of familial amyotrophic lateral sclerosis (ALS) and a small proportion of sporadic ALS cases. We sought to examine clinical and neurophysiological features of familial and sporadic ALS with C9ORF72 expansions.
METHODS: C9ORF72 was screened for expansions in familial and sporadic ALS. Clinical features of expansion positive cases are described. Cortical excitability studies used novel threshold tracking transcranal magnetic stimulation techniques with motor evoked responses recorded over the abductor pollicis brevis. RESULTS AND
CONCLUSIONS: Analysis of large clinical cohorts identified C9ORF72 expansions in 38.5% (72/187) of ALS families and 3.5% (21/606) of sporadic ALS cases. Two expansion positive families were known to carry reported ANG mutations, possibly implicating an oligogenic model of ALS. 6% of familial ALS cases with C9ORF72 expansions were also diagnosed with dementia. The penetrance of ALS was 50% at age 58 years in male subjects and 63 years in female subjects. 100% penetrance of ALS was observed in male subjects by 86 years, while 6% of female subjects remained asymptomatic at age 82 years. Gender specific differences in age of onset were evident, with male subjects significantly more likely to develop ALS at a younger age. Importantly, features of cortical hyperexcitability were apparent in C9ORF72-linked familial ALS as demonstrated by significant reduction in short interval intracortical inhibition and cortical silent period duration along with an increase in intracortical facilitation and motor evoked potential amplitude, indicating that cortical hyperexcitability is an intrinsic process in C9ORF72-linked ALS.

Entities:  

Keywords:  ALS; Dementia; Neurogenetics

Mesh:

Substances:

Year:  2013        PMID: 23463871     DOI: 10.1136/jnnp-2012-304529

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  38 in total

1.  Jump from pre-mutation to pathologic expansion in C9orf72.

Authors:  Zhengrui Xi; Marka van Blitterswijk; Ming Zhang; Philip McGoldrick; Jesse R McLean; Yana Yunusova; Erin Knock; Danielle Moreno; Christine Sato; Paul M McKeever; Raphael Schneider; Julia Keith; Nicolae Petrescu; Paul Fraser; Maria Carmela Tartaglia; Matthew C Baker; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Ian R Mackenzie; Rosa Rademakers; Janice Robertson; Lorne Zinman; Ekaterina Rogaeva
Journal:  Am J Hum Genet       Date:  2015-05-21       Impact factor: 11.025

Review 2.  C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Authors:  Jennifer S Yokoyama; Daniel W Sirkis; Bruce L Miller
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

Review 3.  Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy.

Authors:  Dzung Do-Ha; Yossi Buskila; Lezanne Ooi
Journal:  Mol Neurobiol       Date:  2017-02-03       Impact factor: 5.590

4.  Microtubule defects & Neurodegeneration.

Authors:  Fiona J Baird; Craig L Bennett
Journal:  J Genet Syndr Gene Ther       Date:  2013-12-06

5.  Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease.

Authors:  Aaron Burberry; Naoki Suzuki; Jin-Yuan Wang; Rob Moccia; Daniel A Mordes; Morag H Stewart; Satomi Suzuki-Uematsu; Sulagna Ghosh; Ajay Singh; Florian T Merkle; Kathryn Koszka; Quan-Zhen Li; Leonard Zon; Derrick J Rossi; Jennifer J Trowbridge; Luigi D Notarangelo; Kevin Eggan
Journal:  Sci Transl Med       Date:  2016-07-13       Impact factor: 17.956

Review 6.  Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.

Authors:  Ashley F Curtis; Mario Masellis; Ging-Yuek Robin Hsiung; Rahim Moineddin; Kathy Zhang; Bonnie Au; Geneva Millett; Ian Mackenzie; Ekaterina Rogaeva; Mary C Tierney
Journal:  Neurology       Date:  2017-09-15       Impact factor: 9.910

7.  Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease.

Authors:  Juhyun Kim; Ethan G Hughes; Ashwin S Shetty; Paola Arlotta; Loyal A Goff; Dwight E Bergles; Solange P Brown
Journal:  J Neurosci       Date:  2017-08-17       Impact factor: 6.167

8.  On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease.

Authors:  Tatsuya Osaki; Sebastien G M Uzel; Roger D Kamm
Journal:  Nat Protoc       Date:  2020-01-13       Impact factor: 13.491

9.  Electrical impedance myography (EIM) in a natural history study of C9ORF72 mutation carriers.

Authors:  Michelle B Offit; Tianxia Wu; Mary Kay Floeter; Tanya J Lehky
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-04-21       Impact factor: 4.092

Review 10.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.